Abstract:OBJECTIVE:To design shRNA targeted to human vascular endothelial growth factor (VEGF) and to evaluate the effect of VEGF. shRNA on expression of VEGF in human retinal pigment epithelium (RPE) cells in vitro.METHODS:Human RPE cells were isolated with enzyme-assisted microdissection. The cells were identified by immunohistochemical method with antibody to cytokeratin and S-100. Plasma DNA was identified via restriction enzyme EcoRI and SamI. shRNAs (P1, P2) specific for human VEGF were designed. DNA expression vector is pSilencer 4.1-CMV of Ambion company. P3 is negative control nonspecific shRNA. There are 5 groups. Group 1: VEGF in cultured human RPE exposed to 100 micromol/L CoCl2 30 h; Group 2: VEGF in cultured human RPE in normal culture medium; Group 3, 4, 5: VEGF in cultured human RPE exposed to 100 micromol/L CoCl2 30 h after P1, P2, P3 transfection, respectively. VEGF level in conditioned media was measured by Western blot.RESULTS:The cells in culture could be stained with both cytokeratin and S-100 antibodies. The length of two fragment was 3.3 kb and 1.6 kb, respectively, which indicated that the extraction and purification were successful. The expression of VEGF in RPE was increased significantly (P < 0. 001) in group 1 as compared with group 2. Hypoxia-induced upregulation of human VEGF is halted by siRNA application in vitro (P < 0. 001 and P < 0. 001 in group 3 and 4 compared with group 1, respectively). shRNAs targeted hVEGF effectively and specifically inhibited hypoxia-induced VEGF levels in human RPE. The level of VEGF was reduced 65.9% and 52.4% in groups 3 and 4, respectively. There was no difference between group 5 and 1 (P = 0. 147). There was no difference of beta-actin production in RPE cells among groups.CONCLUSIONS:Delivery of shRNA can be used in vitro to target specific RNAs of VEGF and to reduce the level of the specific protein product (VEGF) in the targeted cells (human RPE). This work established the basis for the using of RNA interference in studies of retinal biology and for the treatment of a variety of retinal angiogenic diseases, especially the choroidal neovascularization.

Construction and Expression of Eukaryotic Expression Plasmids of Shrna Targeting the PPARγ Gene

Construction and identification of RNA interference vector targeting PPARγ gene

[Construction of Shrna Expression Vector Silencing Kir6.2 Gene and to Study Its Influence on the Proliferation and Invasion of HepG2 Cells].

Construction and Identification of PPARγ Shrna Lentiviral Vector in Rats

Construction of Small Hair RNA Lentiviral Vectors Targeting PCSK9 Gene and Its Silent Effects on PCSK9 Gene

Construction and identification of eukaryotic plasmid expression vectors encoding the short hairpin RNA targeting human SIRT1

Construction and Evaluation of Shrna Recombinant Plasmids Targeting Mouse Dppa2 Gene

Three New Shrna Expression Vectors Targeting the CYP3A4 Coding Sequence to Inhibit Its Expression

Construction and Identification of Eukaryotic Expression Plasmid Encoding Shrna Against CXCR1 Gene

Effects of Shrna Targeting VEGF on VEGF Mrna Expression in Gastric Cancer Cells

Construction of the recombinant adenovirus mediated short hairpin RNA to silence Polo-like kinase 1 and its biomedical application

Construction of high efficient eukaryotic expression vector carrying human β3-adrenoceptor gene and its significance

Short Hairpin RNA Targeting Vascular Endothelial Growth Factor Inhibits Expression of Vascular Endothelial Cell in Human GBC-SD Cells

[Construction of Shrna Expressing Plasmid Targeted Rat NogoB and Observation of the Effection about NogoB on Hepatic Stellate Cells].

A Study in Construction of Short Hairpin Small Interfering RNA Expression Vector Target Human Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Gene and Its Silencing Effect in Human Umbilical Vascular Endothelial Cells

Construction of Eukaryotic Expression Plasmid Expressing Shrna Targeting VEGF and NGF

Construction of pTZU6+l RNAi system of inhibiting hypoxia inducible factor-1 activity

Establishment and identification of small hairpin interfering RNA eukaryotic expression vectors of human platelet-derived growth factor A

Short Hairpin RNA Targeting Vascular Endothelial Growth Factor Effectively Inhibits Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelium

Effect of RNA interference targeting at peroxisome proliferator-activated receptor gamma gene on angiogenesis of hepatocellular carcinoma in nude mice

Construction and identification of shRNA eukaryotic expression vectors targeting to prohibitin gene